Pharmafile Logo
Pharmafocus logo
Advanced Search

Zelboraf

Showing 4 posts of 19 posts found.

Zelboraf image

European approval for Roche’s Zelboraf

February 20, 2012
Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma

Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma.  Zelboraf (vemurafenib) is now available in …

News
Roche picture

EMA panel gives positive opinion for Roche’s Zelboraf

December 16, 2011
Sales and Marketing EMA, Roche, Zelboraf

The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf.  The European regulator’s Committee for Medicinal …

News

Roche to show new cancer data at European congress

September 20, 2011
Research and Development Cancer, Roche, T-DM1, Zelboraf, avastin

Roche will highlight a range of new approaches in targeting cancer at the upcoming European cancer conference. In a series …

News
Roche

Roche’s Zelboraf approved by FDA months ahead of schedule

August 18, 2011
Sales and Marketing Yervoy, Zelboraf, skin cancer

The FDA has approved Roche and Daiichi Sankyo’s new skin cancer drug Zelboraf two months ahead of schedule. Zelboraf (vemurafenib) …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026